Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, manufacture and commercialization of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. In December 2010, Pacira announced that its New Drug Application (NDA) for EXPAREL, the company's most advanced investigational product candidate, had been accepted for filing by the U.S. Food and Drug Administration (FDA). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of July 28, 2011 for the review of the EXPAREL NDA. EXPAREL is a bupivacaine-based product and has completed extensive Phase 3 clinical development for postoperative analgesia by infiltration. EXPAREL consists of bupivacaine encapsulated in DepoFoam, which is designed to address the limitations of widely used medications by enhancing their dosing and/or administration profile. Additional information about Pacira is available at www.pacira.com.

About EXPAREL™

EXPAREL is Pacira's proprietary drug candidate consisting of bupivacaine encapsulated in DepoFoam®, both of which are currently used separately in FDA-approved products. Bupivacaine is a well-characterized anesthetic/analgesic that has an established safety profile with more than 20 years of use in the United States. Market data indicate that there is an unmet medical need for a longer-acting anesthetic/analgesic for postsurgical pain management. Several Phase 2 and Phase 3 clinical trials have been completed for EXPAREL and suggest statistically significant reduction of pain in soft tissue and orthopedic surgery in different surgical models. Clinical data from Phase 3 trial 316 suggests that EXPAREL provides analgesia for up to 72 hours post-surgery, the primary endpoint for the trial. The safety of EXPAREL was evaluated in 10 randomized, double-blind, local adm'/>"/>

(Date:7/31/2015)... , July 31, 2015 Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, asthma ... of Yujiro S. Hata to its board ... in business and corporate development is a tremendous asset ... president and chief executive officer of Xencor. "Xencor faces ...

(Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 Edwards ... the science of heart valves and hemodynamic monitoring, today announced ... company,s Board of Directors. "Bob is an ardent ... been a true privilege to have him on Edwards, board ... A. Mussallem , Edwards, chairman and CEO. "Bob has provided ...

(Date:7/30/2015)... Calif. , July 30, 2015 IRIDEX ... will release its second quarter 2015 financial results after ... In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, ... the quarter and other business developments. Interested ...

... Robert C. Gallo Foundation for AIDS and Virus ... as director of international relations. The foundation ... internationally known for expertise in HIV prevention, treatment ... producing groundbreaking HIV research."It is an honor to ...

(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source ... in Chicago at Grant Park. The festival will end on Sunday, August 2nd. ... Chicago for the annual Lollapalooza. This unique and unbelievably popular festival attracts the ...

(Date:7/31/2015)... ... 31, 2015 , ... The 2nd annual Ride to Fight On will start ... 3, 2015. The Ride to Fight On is a cycling fundraiser that benefits the ... West Clinic and The University of Tennessee Health Science Center. A health and wellness ...

(Date:7/31/2015)... ... ... to the article published July 27 on My News LA, a fire that ... the city’s fire department before it caused major damage throughout the building. The article also ... it was a fire alarm system that tipped off fire fighters so they could arrive ...

(Date:7/31/2015)... ... July 31, 2015 , ... ... readers and potential patients alike on various plastic surgery procedures including, but not ... include such popular dermatology procedures like Botox and fillers. , Staying up ...

... N.J., Nov. 10 The New Jersey Hospital Association has ... them protect patients, staff and visitors from H1N1 influenza. , ... for spreading infection in both inpatient and outpatient areas. The ... the age of 18. No individuals under the age ...

... 10 Reportlinker.com announces that a new ... catalogue. , Ophthalmology and Optometry ... http://www.reportlinker.com/p0161962/Ophthalmology-and-Optometry-Macular-Degeneration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , Life Science Analytics, ... information on the current drug pipeline. This ...

... is available in Spanish . , A research team ... presence of the parasite Anisakis spp in anchovies of the ... insist on freezing or cooking fish before consuming it. Although restaurants ... the hours at -20 C", say the UGR scientists, who ...

... lot to do with the foods you eat. To ... healthy meals, the National Heart, Lung, and Blood Institute (NHLBI) ... the Beat Recipes: Deliciously Healthy Dinners. The new cookbook ... Mediterranean, and American cuisine that are good for your heart ...